NORTH CHICAGO, Ill. , Sept. 9, 2022 /PRNewswire/ — The board of directors associated with AbbVie Inc. (  NYSE: ABBV ) today declared a quarterly cash dividend regarding $1. 41 per share.  

The cash dividend is payable November 15, 2022 , to stockholders of record at the close involving business on October 14, 2022 .

Since the company’s inception in 2013, AbbVie has increased its dividend by more than 250 percent. AbbVie is a member of the particular S& P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues nowadays and address the medical challenges connected with tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s wellness and gastroenterology, in addition to products and services across the Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at  www.abbvie.com. Follow @abbvie upon Twitter , Facebook , Instagram , YouTube   and LinkedIn .

SOURCE AbbVie

Leave a Reply

Your email address will not be published.